Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Uterine Myomas: A Systematic Review and Network Meta-analysis of Efficacy Parameters and Adverse Effects

Telek S. B., Gurbuz Z., Kalafat E., Ata B.

JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, cilt.29, sa.5, ss.613-625, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 29 Sayı: 5
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1016/j.jmig.2021.12.011
  • Dergi Adı: JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.613-625
  • Anahtar Kelimeler: Abnormal uterine bleeding, GnRH analog, Leiomyomata, Oral GnRH antagonists, Quality of life, Uterine myoma, ELAGOLIX, FIBROIDS, LEIOMYOMAS, MANAGEMENT, BURDEN, WOMEN
  • İstanbul Üniversitesi Adresli: Hayır

Özet

Objective: The aim of this systematic review is to gather and synthesize evidence regarding the use of oral gonadotrophin-releasing hormone (GnRH) antagonist for the treatment of bleeding associated with uterine myomas.